The use of herbs for treating cardiovascular disease

Seminars in Integrative Medicine

Volumn 2, Issue 1, 2004, Pages 23-35

  Frishman, William H ^a,b,c   Sinatra, Stephen T ^a,b,c   Moizuddin, Mohammed ^a,b,c  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE; ANTINEOPLASTIC AGENT; BERBERINE; CALCIUM; CARDIAC GLYCOSIDE; CRATAEGUS EXTRACT; DIGITALIS; DIGITALIS LANATA EXTRACT; DIGITALIS PURPUREA EXTRACT; DIGITOXIN; DIGOXIN; DILTIAZEM; DOPAMINE; EPHEDRINE; GALLOPAMIL; HERBACEOUS AGENT; NON PRESCRIPTION DRUG; NORADRENALIN; PACLITAXEL; PLACEBO; PLANT MEDICINAL PRODUCT; RAUWOLFIA EXTRACT; RESERPINE; SALICIN; SEROTONIN; STEPHANIA TETRANDRA EXTRACT; TETRANDRINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL;

BLEEDING; BRADYCARDIA; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DEPRESSION; DIARRHEA; DIGITALIS INTOXICATION; DRUG CROSS REACTIVITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG INTOXICATION; DRUG MARKETING; DRUG MECHANISM; DRUG SAFETY; DRUG SYNTHESIS; DRUG USE; FOOD AND DRUG ADMINISTRATION; HEART ARREST; HEART ARRHYTHMIA; HEART DEATH; HEART VENTRICLE TACHYCARDIA; HEPATITIS; HERB; HUMAN; HYPERTENSION; HYPOTENSION; MEDICOLEGAL ASPECT; MENTAL CONCENTRATION; NONHUMAN; NOSE CONGESTION; RADIOIMMUNOASSAY; RESPIRATORY FAILURE; REVIEW; SEDATION; SHOCK; SIDE EFFECT; STOMACH ACID SECRETION; SUICIDE; UNITED STATES;

EID: 5144224865     PISSN: 15431150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sigm.2004.05.002     Document Type: Review

References (73)

1. Goldman P. Herbal medicines today and the roots of modern pharmacology Ann Intern Med 135 2001 594
2. Sinatra S.T. Frishman W.H. Peterson S.J. et al. Use of alternative/complementary medicine in treating cardiovascular disease in: Frishman W.H. Sonnenblick E.H. Sica D.A. (Eds.) Cardiovascular Pharmacotherapeutics (ed 2) 2003 857 McGraw Hill New York, NY
3. Tyler V.E. Herbs of choice The Therapeutic Use of Phytomedicinals 1994 Pharmaceutical Product Press New York, NY
4. Morris C.A. Avorn J. Internet marketing of herbal products JAMA 290 2002 1505
5. Garrard J. Harms S. Eberly L.E. et al. Variations in product choices of frequently purchased herbs. Caveat Emptor Arch Intern Med 163 2003 2290
6. Straus S.E. Herbal medicines: What's in the bottle? N Engl J Med 347 2002 1997
7. DeSmet P.A.G.M. Herbal remedies N Engl J Med 347 2002 2046
8. Marcus D.M. Grollman A.P. Botancial medicines: The need for new regulations N Engl J Med 347 2002 2073
9. Ang-Lee M.K. Moss J. Yuan C.-S. Herbal medicines and perioperative care JAMA 286 2001 208
10. Slifman N.R. Obermeyer W.R. Aloi B.K. et al. Contamination of botanical dietary supplements by Digitalis lanata N Engl J Med 339 1998 806
11. Radford D.J. Gillies A.D. Hinds J.A. et al. Naturally occurring cardiac glycosides Med J Aust 144 1986 540
12. Zeng X.-H. Zeng X.-J. Li Y.-Y. Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 92 2003 173
13. Rauwolfia alkaloids, in USP DI, Vol I: Drug Information for the Health Care Professional (ed 16) 1996 United States Pharmacopeial Convention Rockville, MD
14. Sutter M.C. Wang Y.X. Recent cardiovascular drugs from Chinese medicinal plants Cardiovasc Res 27 1993 1891
15. Kawashima K. Hayakawa T. Miwa Y. et al. Structure and hypotensive activity relationships of tetrandrine derivatives in stroke-prone spontaneously hypertensive rats Gen Pharmacol 21 1990 343
16. Ody P. The Complete Medicinal Herbal 1993 Dorling Kindersley New York, NY
17. Kuramochi T. Chu J. Suga T. Gou-teng (from Uncaria rhynchophylla Miquel) induced endothelium-dependent and independent relaxations in the isolated rat aorta Life Sci 54 1994 2061
18. Chang Q. Zuo Z. Harrison F. et al. Hawthorn J Clin Pharmacol 42 2002 605
19. Vibes J. Lasserre B. Gleye J. et al. Inhibition of thromboxane A2 biosynthesis in vitro by the main components of Crataegus oxyacantha (hawthorn) flower heads Prostaglandins Leukotrienes Essent Fatty Acids 50 1994 173
20. Shanthi S. Parasakthy K. Deepalakshmi P.D. et al. Hypolipidemic activity of tincture of Crataegus in rats Indian J Biochem Biophys 31 1994 143
21. Nasa Y. Hashizume H. Hoque A.N. et al. Protective effect of Crataegus extract on the cardiac mechanical dysfunction in isolated perfused working rat heart Arzneim-Forsch 43 1993 945
22. Roddewig C. Hensel H. Reaction of local myocardial blood flow in non-anesthetized dogs and anesthetized cats to the oral and parenteral administration of a Crataegus fraction (oligomere procyanidines) [German] Arzneim-Forsch 27 1977 1407
23. Taskov M. On the coronary and cardiotonic action of crataemon Acta Physiol Pharmacol Bulg 3 1977 53
24. Blesken R. Crataegus in cardiology (German) Fortschr Med 110 1992 290
25. Baughman K.L. Bradley D.J. Hawthorn extract: Is it time to turn over a new leaf? Am J Med 114 2003 700
26. Pittler M.H. Schmidt K. Ernst E. Hawthorn extract for treating chronic heart failure: Meta-analysis of randomized trials Am J Med 114 2003 665
27. Holubarsch C.J. Colucci W.S. Meinertz T. et al. Survival and prognosis: Investigation of Crataegus extract WS 1442 in congestive heart failure (SPICE)-rationale, study design and study protocol Eur J Heart Fail 2 2000 431
28. Schussler M. Holzl J. Fricke U. Myocardial effects of flavonoids from Crataegus species Arzneim-Forsch 45 1995 842
29. Zhang W. Wojta J. Binder B.R. Effect of notoginsenoside R1 on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells Arterioscler Thromb 14 1994 1040
30. Lin S.G. Zheng X.L. Chen Q.Y. et al. Effect of Panax notoginseng saponins on increased proliferation of cultured aortic smooth muscle cells stimulated by hypercholesterolemic serum Zhongguo Yao Li Xue Bao 14 1993 314
31. Ackermann R.T. Mulrow C.D. Ramirez G. et al. Garlic shows promise for improving some cardiovascular risk factors Arch Intern Med 161 2001 813
32. Silagy C.A. Neil H.A. A meta-analysis of the effect of garlic on blood pressure J Hypertens 12 1994 463
33. Silagy C. Neil A. Garlic as a lipid lowering agent. A meta-analysis J R Coll Physicians Lond 28 1994 39
34. Mader F.H. Treatment of hyperlipidaemia with garlic-powder tablets: Evidence from the German Association of General Practitioners multicentric placebo-controlled, double-blind study Arzneim-Forsch 40 1990 1111
35. Warshafsky S. Kamer R. Sivak S. Effect of garlic on total serum cholesterol Ann Intern Med 119 1993 599
36. Stevermer J.J. Lindbloom E.J. Ginkgo biloba for dementia J Fam Pract 46 1998 20
37. Solomon P.R. Adams F. Silver A. et al. Ginkgo for memory enhancement: A randomized controlled trial JAMA 288 2002 835
38. Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's wort, ginseng, echinacea, saw palmetto, and kava Ann Intern Med 136 2002 42
39. Pittler M.H. Ernst E. Ginkgo biloba extract for the treatment of intermittent claudication: A meta-analysis of randomized trials Am J Med 108 2000 276
40. Vale S. Subarachnoid haemorrhage associated with Ginkgo biloba Lancet 352 1998 36
41. Matthews M.K. Association of Ginkgo biloba with intracerebral hemorrhage Neurology 50 1998 1933
42. Rowin J. Lewis S.L. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion Neurology 46 1996 1775
43. Gianni L. Dreitlein W.B. Some popular OTC herbals can interact with anticoagulant therapy US Pharm 23 1998 80
44. Offord E.A. Mace K. Ruffieux C. et al. Rosemary components inhibit benzo(a)pyrene-induced genotoxicity in human bronchial cells Carcinogenesis 16 1995 2057
45. Haraguchi H. Saito T. Okamura N. et al. Inhibition of lipid peroxidation and superoxide generation by diterpenoids from Rosmarinus officinalis Planta Med 61 1995 333
46. Larrondo J.V. Agut M. Calvo-Torras M.A. Antimicrobial activity of essences from labiates Microbios 82 1995 171
47. al-Hader A.A. Hasan Z.A. Aqel M.B. Hyperglycemic and insulin release inhibiting effects of Rosmarinus officinalis J Ethnopharmacol 43 1994 217
48. Tyler V.E. The Honest Herbal: A Sensible Guide to the Use of Herbs and Related Remedies: (ed 3) 1993 Pharmaceutical Product Press New York, NY
49. Diehm C. Vollbrecht D. Amendt K. et al. Medical edema protection-Clinical benefit in patients with chronic deep vein incompetence: A placebo controlled double blind study Vasa 21 1992 188
50. Lang W. Studies on the percutaneous absorption of 3H-aescin in pigs Res Exp Med 169 1977 175
51. Bouskela E. Cyrino F.Z. Marcelon G. Possible mechanisms for the inhibitory effect of Ruscus extract on increased microvascular permeability induced by histamine in hamster cheek pouch J Cardiovasc Pharmacol 24 1994 281
52. Bouskela E. Cyrino F.Z. Marcelon G. Possible mechanisms for the venular constriction elicited by Ruscus extract on hamster cheek pouch J Cardiovasc Pharmacol 24 1994 165
53. Bouskela E. Cyrino F.Z. Marcelon G. Effects of Ruscus extract on the internal diameter of arterioles and venules of the hamster cheek pouch microcirculation J Cardiovasc Pharmacol 22 1993 221
54. Berg D. Venous constriction by local administration of ruscus extract (German) Fortschr Med 108 1990 473
55. Berg D. Venous tonicity in pregnancy varicose veins (German) Fortschr Med 110 1992 67
56. Li Y.P. Wang Y.M. Evaluation of tussilagone: A cardiovascular respiratory stimulant isolated from Chinese herbal medicine Gen Pharmacol 19 1988 261
57. Shekelle P.G. Hardy M.L. Morton S.C. et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: A meta-analysis JAMA 289 2003 1537
58. Fontanarosa P.B. Rennie D. DeAngelis C.D. The need for regulation of dietary supplements: Lessons from ephedra (editorial) JAMA 289 2003 1568
59. Samenuk D. Link M.S. Homoud M.K. et al. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine Mayo Clin Proc 77 2002 12
60. Commentary: American Society for Clinical Pharmacology and Therapeutics position statement on the public health risks of ephedra Clin Pharmacol Ther 74 2003 403
61. Gardner S.F. Franks A.M. Gurley B.J. et al. Effect of a multicomponent, ephedra-containing dietary supplement (Metabolife 356) on Holter monitoring and hemostatic parameters in healthy volunteers Am J Cardiol 91 2003 1510
62. Bent S. Tiedt T.N. Odden M.C. et al. The relative safety of ephedra compared with other herbal products Ann Intern Med 138 2003 468
63. Chan T.Y.K. Chan J.C.N. Tomlinson B. et al. Chinese herbal medicines revisited: The Hong Kong perspective Lancet 342 1993 1532
64. Horowitz R.S. Feldhaus K. Dart R.C. et al. The clinical spectrum of Jin Bu Huan toxicity Arch Intern Med 156 1996 899
65. Izzo A.A. Ernst E. Interactions between herbal medicines and prescribed drugs Drugs 61 2001 2163
66. Wang Z. Gorski C. Hamman M.A. et al. The effects of St. John's Wort (Hypericum perforatum) on human cytochrome P450 activity Clin Pharmacol Ther 70 2001 317
67. Mueller S.C. Uehleke B. Woehling H. et al. Effect of St. John's Wort dose and preparations on the pharmacokinetics of digoxin Clin Pharmacol Therap 75 2004 546
68. Knipschild P. Alternative treatments: Do they work? Lancet 356 2000 S4
69. Lin M.C. Nahin R. Gershwin E. et al. State of complementary and alternative medicine in cardiovascular, lung, and blood research: Executive summary of a workshop Circulation 103 2001 2038
70. Vandenbroucke J.P. de Craen A.J.M. Alternative medicine: A "mirror image" for scientific reasoning in conventional medicine Ann Intern Med 135 2001 507
71. Cassetta J.A. Valli G. Giardian E.-G.V. Cardiovascular benefit and adverse effects of common herbal therapies Cardiol Rev 21 2004 35
72. Stein C.M. Are herbal products dietary supplements or drugs? An important question for public safety Clin Pharmacol Ther 71 2002 411
73. Krucoff M.W. Liebowitz R. Vogel J.H.K. et al. Complementary and alternative medical therapy in cardiovascular care in: Fuster V. Alexander R.W. O'Rourke R.A. (Eds.) Hurst's The Heart (ed 11) 2004 2463-2472 McGraw Hill New York